XML 72 R60.htm IDEA: XBRL DOCUMENT v3.21.1
Common Stock and Stockholders' Equity - Stock Plan and Stock Options (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Dec. 29, 2020
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Common Stock and Stockholders' Equity        
Trading days 4 days      
Shares available for grant   12,229,932    
Stock options        
Common Stock and Stockholders' Equity        
Vesting period   4 years    
Stock options | Maximum        
Common Stock and Stockholders' Equity        
Exercisable period (in years)   10 years    
RSUs        
Common Stock and Stockholders' Equity        
Vesting period   3 years    
RSUs | Maximum        
Common Stock and Stockholders' Equity        
Vesting period   4 years    
2015 Incentive Award Plan        
Number of Shares Outstanding        
Balance, beginning of period (in shares)   5,826,685    
Stock option grants and assumed awards (in shares)   3,688    
Stock option exercised (in shares)   (1,237,399)    
Stock options forfeited (in shares)   (44,031)    
Balance, end of period (in shares)   4,548,943   5,826,685
Vested or expected to vest at end of period (in shares)   4,548,943    
Exercisable as of end of period (in shares)   3,700,190    
Weighted-Average Exercise Price        
Balance, beginning of period (in dollars per share)   $ 17.19    
Stock option grants and assumed awards (in dollars per share)   107.06    
Stock option exercised (in dollars per share)   9.62    
Stock options forfeited (in dollars per share)   14.47    
Balance, end of period (in dollars per share)   19.41   $ 17.19
Vested or expected to vest at end of period (in dollars per share)   19.41    
Exercisable as of end of period (in dollars per share)   $ 16.88    
Weighted-average remaining contractual life in Years        
Weighted-average remaining contractual life (in years)   5 years 8 months 8 days   5 years 3 months 21 days
Vested or expected to vest at end of period (in years)   5 years 8 months 8 days    
Exercisable as of end of period (in years)   5 years 3 months 29 days    
Aggregate Intrinsic Value        
Aggregate Intrinsic Value   $ 738,498   $ 1,064,944
Stock options exercised   (212,993)    
Vested or expected to vest at end of period   738,498    
Exercisable as of end of period   610,040    
Grant-date fair value of stock options granted during the period   $ 400 $ 300